Nanotechnology Now - Press Release: Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: INIX, BPAX, GLOW, LB

Home > Press > Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: INIX, BPAX, GLOW, LB

Abstract:
WallSt.net's 3-Minute Press Show is a daily video program hosted by WallSt.net reporter, Tracee Tolentino.

Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: INIX, BPAX, GLOW, LB

New York, NY | Posted on March 20th, 2008

Shows air Monday through Friday on: www.wallst.net/wallst_tv/3_minute_press_show/index.php.

WallSt.net's 3-Minute Press Show features in-depth interviews with public company executives on their company and most recent press releases. The show is designed to provide viewers with insight into a company's most recent press release, and its impact on the company's growth.

The following executives were interviewed on today's show: -- Doug Spadaro, CEO of iFinix Corp. (Pink Sheets: INIX) (www.ifinix.com) -- Stephen M. Simes, CEO of BioSante Phamaceuticals, Inc. (www.biosantepharma.com/) -- Michael Brandofino, President and CEO of Glowpoint, Inc. (BULLETIN BOARD: GLOW) (www.glowpoint.com) -- Craig LaBarge, President and CEO of LaBarge, Inc. (www.labarge.com)

####

About WallStreet Direct, Inc.
WallStreet Direct, Inc. a wholly-owned subsidiary of Financial Media Group, Inc., owns and operates WallSt.net (www.wallst.net), a leading source of up-to-the-minute business news, comprehensive financial tools and original multimedia content for the investment community. In addition to WallSt.net, WallStreet Direct owns and operates WallStRadio (radio.wallst.net) an online hub for business podcasts from well-known business news personalities and publishers. We have received ten thousand seven hundred seventy dollars from BioSante Pharmaceuticals, Inc. for media and advertising services. We have received nine hundred ninety five dollars from Glowpoint, Inc. for media and advertising services. We have received three thousand one hundred fifty dollars and two million five hundred thousand restricted shares of INIX from IFinix Corporation for media and advertising services. We have received four hundred ninety five dollars from LaBarge, Inc. for the dissemination of this press release. To read our full disclaimer, and for a complete list of our advertisers, and advertising relationships, visit www.wallst.net/disclaimer/disclaimer.php.

About iFinix Corp.

iFinix is a diversified information technology services and solutions company with expertise in systems integration, outsourcing, infrastructure and server technology. iFinix has established a product line that delivers financial and business information with streaming, real-time market data, news and analytics to professionals and active individual investors. The company's suite of products includes iFinix RealTime, iFinix Trader and eFinix. Visit www.ifinix.com.

About BioSante Pharmaceuticals, Inc.

BioSante is developing a pipeline of products primarily for transdermal administration of estradiol and testosterone. BioSante's lead products include LibiGel(R) (transdermal testosterone gel) in Phase III clinical development by BioSante under a U.S. Food and Drug Administration (FDA) SPA (Special Protocol Assessment) for the treatment of female sexual dysfunction (FSD), and Elestrin(TM) (estradiol gel) developed through FDA approval by BioSante, indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, marketed in the U.S. by Nycomed US, BioSante's licensee. Also in development are Bio-T-Gel(TM), a testosterone gel for male hypogonadism, and an oral contraceptive in Phase II clinical development using BioSante patented technology. The current market in the U.S. for estrogen and testosterone products is approximately $2.5 billion and for oral contraceptives approximately $3.0 billion. The company also is developing its calcium phosphate nanotechnology (CaP) for novel vaccines, drug delivery and aesthetic medicine (BioLook(TM)). Additional information is available online at: www.biosantepharma.com.

About Glowpoint, Inc.

Glowpoint, Inc. is a premiere, IP-based managed video communications services provider. Glowpoint is innovating video communications with services supporting traditional video conferencing, Telepresence VNOC, Broadcast Content Acquisition & Delivery, and Call Center Applications. Glowpoint's services are delivered over a robust, video-centric network that reaches around the world and serves clients ranging from Fortune 100 enterprises and leading broadcast networks to SMB markets. Glowpoint is headquartered in Hillside, New Jersey. To learn more, visit www.glowpoint.com.

About LaBarge, Inc.

LaBarge, Inc. is a broad-based provider of electronics to technology-driven companies in such diverse markets as natural resources, defense and industrial. The Company provides its customers with sophisticated electronic and electromechanical products through contract design and manufacturing services. Headquartered in St. Louis, LaBarge has operations in Arkansas, Missouri, Oklahoma, Pennsylvania and Texas. The Company's Web site may be accessed at www.labarge.com.

For more information, please click here

Contacts:
WallSt.net
800-4-WALLST

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: